Sudden hearing loss and early hyperbaric oxygen... (2023 study) Skip to main content
Review Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2023

Sudden hearing loss and early hyperbaric oxygen therapy: A preliminary study.

Aldè M, Cantarella G, Piatti G, Ambrosetti U, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers reviewed hospital charts from 2012 to 2021 of adults with sudden hearing loss of unknown cause who started hyperbaric oxygen therapy within three days and did not take corticosteroids.

What They Found

In this retrospective chart review of 49 adults with idiopathic sudden sensorineural hearing loss who received hyperbaric oxygen (HBO2) without steroids, 35 patients (71.4%) had complete hearing recovery and the average hearing threshold improved from 69.8 dB to 31.4 dB (p less than 0.001). The group had 26 men and 23 women, with a mean age of 47 years. All patients started HBO2 within 72 hours of symptom onset. The protocol was at least 10 sessions of 85 minutes each, breathing pure oxygen at 2.5 atmospheres absolute. Among patients who fully recovered, the abstract reports no significant differences by sex, by right or left ear, or by initial grade of hearing loss.

What This Means for Canadian Patients

This abstract looked at adults with sudden hearing loss of unknown cause who did not take corticosteroids because of contraindications or concerns about side effects. The authors suggest that starting HBO2 within three days of symptom onset, without steroids, could have a positive impact. The study did not compare HBO2 with steroid treatment, so it cannot tell patients which option is better. Anyone with sudden hearing loss should talk with a physician right away, because the abstract calls it a time-sensitive urgent condition.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective review of 49 patients from chart records, and the abstract describes no comparison group, so it cannot show that HBO2 itself caused the hearing recovery.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 37302077
Year Published 2023
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Adult; Male; Female; Humans; Middle Aged; Hearing Loss, Sudden; Hyperbaric Oxygenation; Hearing; Hearing Loss, Sensorineural; Retrospective Studies; Treatment Outcome

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology